2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC)

Authors

  • Fred Saad Centre Hospitalier de l’Université de Montréal
  • Armen Aprikian McGill University Health Centre
  • Antonio Finelli Division of Urology, University of Toronto
  • Neil E. Fleshner Division of Urology, University of Toronto
  • Martin Gleave Department of Urological Sciences, University of British Columbia
  • Anil Kapoor Division of Urology, Department of Surgery, McMaster University
  • Tamim Niazi Jewish General Hospital, Montreal
  • Scott A. North Department of Medical Oncology, University of Alberta
  • Fréderic Pouliot CHU de Quebec, Université Laval
  • Ricardo A. Rendon Department of Urology, Dalhousie University
  • Bobby Shayegan Division of Urology, Department of Surgery, McMaster University
  • Srikala S. Sridhar Division of Medical Oncology, University of Toronto
  • Alan I. So Department of Urologic Sciences, University of British Columbia
  • Nawaid Usmani Department of Oncology, Division of Radiation Oncology, University of Alberta
  • Eric Vigneault Department of Radiation Oncology, CHU de Quebec, Université Laval
  • Kim N. Chi BC Cancer Agency, Vancouver

DOI:

https://doi.org/10.5489/cuaj.8161

Keywords:

CRPC, guideline

Downloads

Download data is not yet available.

Published

2022-10-27

How to Cite

Saad, F., Aprikian, A., Finelli, A. ., Fleshner, N. E. ., Gleave, M. ., Kapoor, A., … Chi, K. N. (2022). 2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC). Canadian Urological Association Journal, 16(11), E506–15. https://doi.org/10.5489/cuaj.8161

Issue

Section

CUA Guideline